1224288-92-9 Usage
General Description
5-Chloropyrazolo[1,5-a]pyrimidine-3-carbonitrile is an organic compound with the chemical formula C7H3ClN4. It is a heterocyclic compound that contains a pyrazole ring and a pyrimidine ring. This chemical is commonly used in the pharmaceutical industry as a building block for the synthesis of various other organic compounds. It is also known for its potential biological activities, such as antitumor and antimicrobial properties. The compound is typically used as a reagent in organic synthesis and is an important intermediate in the production of pharmaceuticals and agrochemicals. Additionally, it may also have potential applications in the field of medicinal chemistry for the development of new drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 1224288-92-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,4,2,8 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1224288-92:
(9*1)+(8*2)+(7*2)+(6*4)+(5*2)+(4*8)+(3*8)+(2*9)+(1*2)=149
149 % 10 = 9
So 1224288-92-9 is a valid CAS Registry Number.
1224288-92-9Relevant articles and documents
COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK
-
Page/Page column 27; 28, (2017/06/12)
This invention relates to inhibitors of NTRK comprising a pyrazolo[1,5-4]pyrimidine-3-carbonitrile structure. They are active against wild-type NTRK and its resistant mutants.
HETEROAROMATIC COMPOUNDS AS PI3 KINASE MODULATORS AND METHODS OF USE
-
Paragraph 0322; 0323, (2014/09/03)
The present invention provides heteroaromatic derivatives and pharmaceutical acceptable salts and formulations thereof useful in modulating the protein kinase activity, especially phosphatidylinositol 3-kinases (PI3 kinases) and mTOR, and in modulating inter- and/or intra-cellular signaling activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.